首页> 外文OA文献 >MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments

【2h】

MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments

机译：MAP0004，口服吸入的二氢麦角胺用于急性偏头痛的治疗：早期和晚期治疗的功效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

OBJECTIVE: To evaluate the efficacy of MAP0004, an orally inhaled dihydroergotamine, for acute treatment of migraine when administered at various time points from within 1 hour to more than 8 hours after migraine onset.

机译：目的：评估偏头痛发作后1小时至8小时以上的不同时间点口服口服的双氢麦角胺MAP0004对偏头痛的急性治疗效果。

著录项

作者
Tepper, Stewart J.; Kori, Shashidhar H.; Goadsby, Peter J.; Winner, Paul K.; Wang, Min H.; Silberstein, Stephen D.; Cutrer, F. Michael;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: Efficacy of early and late treatments [J] . TepperS.J., KoriS.H., GoadsbyP.J., Mayo Clinic Proceedings . 2011,第10期

机译：MAP0004，口服吸入二氢麦角胺用于偏头痛的急性治疗：早期和晚期治疗的功效
2. Comparable Efficacy and Safety For Exploratory Endpoints Regardless of Pain Severity and Treatment Time after Migraine Onset: Results From a Phase 3 Trial of Orally Inhaled Dihydroergotamine (MAP0004) for the Acute Treatment of Migraine [J] . Tepper S. J., Newman L., Holdbrook F., Headache . 2014,第S1期

机译：无论偏头痛发作后的疼痛程度和治疗时间如何，探索性终点的疗效和安全性均具有可比性：口服吸入性二氢麦角胺（MAP0004）急性偏头痛治疗的3期试验结果
3. Comparable Efficacy and Safety Among Patients with and Without Aura: Orally Inhaled Dihydroergotamine (MAP0004) for the Acute Treatment of Migraine [J] . Winner P., Holdbrook F., Davar G. Headache . 2014,第S1期

机译：有或没有先兆的患者之间的可比疗效和安全性：口服吸入二氢麦角胺（MAP0004）用于急性偏头痛的治疗
4. SAFETY AND USABILITY FACTORS IN DEVELOPMENT OF A NOVEL, AUTOMATED TREATMENT DEVICE FOR ACUTE MIGRAINE [C] . David M. George, Guido Pagnacco, Kevin E. Willey, Annual rocky mountain bioengineering symposium;International ISA biomedical sciences instrumentation symposium . 2017

机译：开发新型自动治疗急性偏头痛的安全性和可用性因素
5. Geographic Variation in the Use of Triptans and Opioids for the Acute Treatment of Migraine Attacks [D] . Lee, Jae Hyun. 2020

机译：使用曲坦和阿片类药物的地理变异用于偏头痛攻击的急性治疗
6. MAP0004 Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments [O] . Stewart J. Tepper, Shashidhar H. Kori, Peter J. Goadsby, 2011

机译：MAP0004口服吸入的二氢麦角胺用于偏头痛的急性治疗：早期和晚期治疗的功效
7. MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine:Efficacy of Early and Late Treatments (vol 86, pg 948, 2011) [O] . Tepper, Stewart J., Kori, Shashidhar H., Goadsby, Peter J., 2011

机译：MAP0004，口服吸入二氢麦角胺用于偏头痛的急性治疗：早期和晚期治疗的功效（第86卷，第948页，2011年）

MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅